NGNE

NGNE

USD

Neurogene Inc. Common Stock

$26.750+0.625 (2.392%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$26.125

Hoch

$26.970

Tief

$23.930

Volumen

0.16M

Unternehmensfundamentaldaten

Marktkapitalisierung

381.8M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.20M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $6.875Aktuell $26.750Hoch $74.49

Ähnliche Nachrichten

Analyst Upgrades

FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy

William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty in its accelerated approval timeline.

Mehr anzeigen
FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Neurogene, Raises Price Target to $65

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Neurogene with a Buy and raises the price target from $45 to $65.

Mehr anzeigen
HC Wainwright & Co. Maintains Buy on Neurogene, Raises Price Target to $65